180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF · Real-Time Price · USD
0.8849
+0.0442 (5.26%)
At close: Jul 10, 2025, 4:00 PM
0.8999
+0.0150 (1.70%)
After-hours: Jul 10, 2025, 7:14 PM EDT
180 Life Sciences Market Cap
180 Life Sciences has a market cap or net worth of $5.04 million as of July 10, 2025. Its market cap has increased by 260.00% in one year.
Market Cap
5.04M
Enterprise Value
1.47M
1-Year Change
260.00%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since June 27, 2017, 180 Life Sciences's market cap has decreased from $125.60M to $5.04M, a decrease of -95.99%. That is a compound annual growth rate of -32.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 4.80M | 33.33% |
| Dec 31, 2024 | 3.60M | 125.00% |
| Dec 29, 2023 | 1.60M | -76.81% |
| Dec 30, 2022 | 6.90M | -94.80% |
| Dec 31, 2021 | 132.70M | 169.72% |
| Dec 31, 2020 | 49.20M | -43.64% |
| Dec 31, 2019 | 87.30M | -42.45% |
| Dec 31, 2018 | 151.70M | 4.98% |
| Dec 29, 2017 | 144.50M | 15.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |